Showing results (1-10 of 803) with videos related to
Sort By:
Pageof 81
European Journal of Haematology|February 1, 1995
All trans retinoic acid enhances human LAK activityC Fegan, R Bailey-Wood, S Coleman, et al.Bone Marrow Transplantation|August 1, 1995
In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantationC Fegan, H Thomas, R Bailey-Wood, et al.British Journal of Haematology|July 1, 1980
Active immunotherapy for the treatment of acute myelogenous leukaemia: report of two controlled trialsJ A Whittaker, R Bailey-Wood, S HutchinsBritish Journal of Cancer|September 1, 1984
Effect of adriamycin on CFUGM at plasma concentrations found following therapeutic infusionsR Bailey-Wood, C M Dallimore, J A WhittakerJournal of Clinical Pathology|February 1, 1995
Antigenaemia during acute graft versus host diseaseC Fegan, S K Jackson, J A WhittakerBone Marrow Transplantation|June 1, 1990
The gut mucosal barrier in bone marrow transplantationC Fegan, C H Poynton, J A WhittakerBone Marrow Transplantation|January 23, 1999
In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemiaS H Lim, S Coleman, R Bailey-WoodLeukemia Research|January 1, 1984
Use of logistic regression analysis to improve prediction of prognosis in acute myeloid leukaemiaR Bailey-Wood, C M Dallimore, S A Smith, et al.British Journal of Haematology|July 27, 2001
Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemiaC Pepper, A Thomas, T Hoy, et al.Leukemia|December 1, 1995
Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive diseaseC Fegan, H Robinson, P Thompson, et al.Pageof 81